(NASDAQ: HYPR) Hyperfine's forecast annual revenue growth rate of 42.89% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 12.31%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 55.74%.
Hyperfine's revenue in 2026 is $10,591,000.On average, 3 Wall Street analysts forecast HYPR's revenue for 2026 to be $1,784,016,543, with the lowest HYPR revenue forecast at $1,714,055,109, and the highest HYPR revenue forecast at $1,836,487,617. On average, 3 Wall Street analysts forecast HYPR's revenue for 2027 to be $2,111,086,242, with the lowest HYPR revenue forecast at $2,028,298,546, and the highest HYPR revenue forecast at $2,173,177,014.
In 2028, HYPR is forecast to generate $2,408,422,332 in revenue, with the lowest revenue forecast at $2,313,974,398 and the highest revenue forecast at $2,479,258,283.